1 |
Buskin, J. N., Upton, R. A., Jones, R., and Williams, R. L., High performance liquid chromatography assay of acebutolol and its metabolites in plasma and urine. J. Chromatogr., 230, 438-442 (1982)
DOI
PUBMED
ScienceOn
|
2 |
Choi, J. S. and Kim,Y.G, Pharmacokinetic changes of diltiazem anddesacetyldiltiazem after oral administration of diltiazem in rabbits with diabetes mellitus induced by alloxan. Biopharm. Drug Dispos., 23, 115-120 (2002)
DOI
ScienceOn
|
3 |
Gabriel, R., Kaye, C. M., and Sankey, M. G., Preliminary observations on the excretion of acebutolol and its acetyl matabolite in the urine and feces of man. J. Pharm. Pharmacol., 33, 386-387 (1981)
DOI
PUBMED
|
4 |
George, C. F. and Gruchy, B. S., Elimination of drugs by active intestinal transport. J. Pharm. Pharmacol., 31, 643-644 (1979)
DOI
PUBMED
|
5 |
Kim, S. H., Kim, W. B., and Lee, M. G., Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus. Biopharm. Drug Dispos., 19, 303-308 (1998)
DOI
ScienceOn
|
6 |
Park, J. H., Lee, W. I., and Lee, M. G., Pharmacokinetic and pharmacodynamic changes of furosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus. Biopharm. Drug Dispos., 19, 357-364 (1998)
DOI
ScienceOn
|
7 |
Flouvat, B., Roux, A., and Chau, N. P., Pharmacokinetics and bioavailability of diacetolol, the main matabolite of acebutolol. Eur. J. Clin. Pharmacol., 19, 287-292 (1981)
DOI
ScienceOn
|
8 |
Gulaid, A. A., James, I. M., and Kaye, C. M., The Pharmacokinetics of acebutolol in man, following the oral administration of acebutolol as a single dose and during and after repeated oral dosing. Biopharm. Drug Dispos., 2, 103-114 (1981)
DOI
ScienceOn
|
9 |
Choi, Y. J., Lee, H. J., Kwon, J. W., Kim, W. B., Yang, J., and Lee, M. G., Pharmacokinetic change of M1, M2, M3, and M4 after intravenous administration of a new anthracycline, DA-125, to alloxan-induced diabetes mellitus. Res. Commun. Mol. Pathol. Pharmacol., 94, 181-192 (1996)
PUBMED
|
10 |
Gwilt, P. R., Nahhas, P. R., and Tracewell, W. G., The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans. Clin. Pharmacokinet., 20, 477-490 (1991)
DOI
ScienceOn
|
11 |
Baker, P. G. and Goulton, J. A., Multicentre study of a once daily dosage of acebutolol in the treatment of hypertension in general practice. J. Int. Med. Res., 7, 201-214 (1979)
DOI
PUBMED
|
12 |
Park, K. J., Yoon, W. H., and Lee, M.G., Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus. J. Pharm. Pharmacol., 48, 1093-1097 (1996)
DOI
PUBMED
ScienceOn
|
13 |
Martin, M. A., Phillips, C. A., and Smith, A. J., Acebutolol in hypertension a double blind trial against placebo. Br. J. Clin. Pharmcol., 6, 351-356 (1978)
DOI
ScienceOn
|
14 |
Choi, J. S. and Choi, B. C., Pharmacokinetic changes of sulfamethoxazole in rabbits with diabetes mellitus induced by alloxan. Res. Commun. Mol. Pathol. Pharmacol., 108, 332-340 (2000)
PUBMED
|
15 |
Pickup, J. C. and Williams, G., Textbook of Diabetes, Blackwell Scientific Publications, Oxford, England, 1, 151-155 (1991)
|
16 |
Lee, H. J., Paik, W. H., and Lee, M. G., Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to alloxaninduced diabetes mellitus rats. Res. Commun. Mol. Pathol. Pharmacol., 89, 165-178. (1995)
PUBMED
|
17 |
O'Connor, P. and Feely, J., Clinical pharmacokinetics and endocrine disorders. Therapeutic implications. Clin. Pharmacokinet., 13, 345-364 (1987)
DOI
ScienceOn
|
18 |
Alhenz-Gelas, F., Plouin, P. F., Ducrocq, M. B., Corvol, P. E., and Menard, J., Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker acebutolol and diuretics in essential hypertension. Am. J. Med., 64, 1005-1012 (1978)
DOI
ScienceOn
|
19 |
Mclean, A. J., Mcnamara, R. J., Souich, P. D., Gibaldi, M., and Lalka, D., Food, splanchnic blood flow and bioavailability of drugs subject to first pass metabolism. Clin. Pharmacol. Ther., 24, 5-10 (1978)
DOI
PUBMED
|
20 |
Basil, J. and Jordan, R., Pharmacological properties of diacetolol, a major metabolite of acebutolol. Eur. J. Pharmacol., 80, 47-56 (1982)
DOI
ScienceOn
|
21 |
Roux, A., Flouvat, B., Chau, N. P., Letac, B. and Lucsko, B., Pharmacokinetics of acebutolol after intravenous bolus administration. Br. J. Clin. Pharmacol., 9, 215-217 (1980)
DOI
PUBMED
ScienceOn
|
22 |
Yamaoka, K., Tanigawara, Y., Nakagawa, T., and Uno, T., A pharmacokinetics analysis program for microcomputer. J. Pharm. Dyn., 4, 879-883 (1971)
|